• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人本位的取舍合理吗?

When are person tradeoffs valid?

机构信息

Department of Clinical Pharmacy & Pharmaceutical Economics & Policy, School of Pharmacy, University of Southern California, Los Angeles, CA 90089-9004, USA.

出版信息

J Health Econ. 2009 Sep;28(5):1018-27. doi: 10.1016/j.jhealeco.2009.06.010. Epub 2009 Jun 25.

DOI:10.1016/j.jhealeco.2009.06.010
PMID:19683816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2763995/
Abstract

The person tradeoff (PTO) is commonly used in health economic applications. However, to date it has no theoretical basis. The purpose of this paper is to provide this basis from a set of assumptions that together justify the most common applications of the PTO method. Our analysis identifies the central assumptions in PTO measurements. We test these assumptions in an experiment, but find only limited support for the validity of the PTO.

摘要

人交换(PTO)在健康经济应用中被广泛使用。然而,迄今为止,它还没有理论基础。本文的目的是从一组假设出发,为 PTO 方法的最常见应用提供理论依据。我们的分析确定了 PTO 测量中的核心假设。我们在实验中检验了这些假设,但只发现了对 PTO 有效性的有限支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccef/2763995/52f8635c1268/nihms-138963-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccef/2763995/4833682f964a/nihms-138963-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccef/2763995/92e108ccdd69/nihms-138963-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccef/2763995/52f8635c1268/nihms-138963-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccef/2763995/4833682f964a/nihms-138963-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccef/2763995/92e108ccdd69/nihms-138963-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccef/2763995/52f8635c1268/nihms-138963-f0003.jpg

相似文献

1
When are person tradeoffs valid?人本位的取舍合理吗?
J Health Econ. 2009 Sep;28(5):1018-27. doi: 10.1016/j.jhealeco.2009.06.010. Epub 2009 Jun 25.
2
[Economic evaluations more and more important in healthcare decision making. Costs must be balanced against benefits also in studies on health economics].[经济评估在医疗保健决策中越来越重要。在卫生经济学研究中,成本也必须与收益相平衡]
Lakartidningen. 2006;103(46):3624-7.
3
Economic impact of disease and injury: counting what matters.疾病和伤害的经济影响:计算重要因素。
BMJ. 2010 Mar 2;340:c924. doi: 10.1136/bmj.c924.
4
Measurement of costs.成本的计量
J Med Assoc Thai. 2008 Jun;91 Suppl 2:S28-37.
5
Strategic costs and preferences revelation in the allocation of resources for health care.医疗保健资源分配中的战略成本与偏好揭示
Int J Health Care Finance Econ. 2010 Sep;10(3):239-56. doi: 10.1007/s10754-010-9079-x. Epub 2010 Mar 23.
6
Cost containment in health care: justification and consequences.医疗保健中的成本控制:理由与后果。
Dev Health Econ Public Policy. 1992;1:245-65. doi: 10.1007/978-94-011-2392-1_12.
7
[Health economics play more and more important role in health care prioritization. Better utilization of the meager health care resources is the goal].卫生经济学在卫生保健资源分配中发挥着越来越重要的作用。更好地利用稀缺的卫生保健资源是目标。
Lakartidningen. 2006;103(46):3617-20, 3622-3.
8
Discrete choice experiments in health economics: distinguishing between the method and its application.健康经济学中的离散选择实验:区分方法及其应用。
Eur J Health Econ. 2005 Dec;6(4):314-6. doi: 10.1007/s10198-005-0304-3.
9
Special issue on health economics and policy: Guest editors' introduction.健康经济学与政策特刊:客座编辑引言
Health Econ. 2017 Sep;26 Suppl 2:3-4. doi: 10.1002/hec.3576.
10
[HEALTH ECONOMIC ANALYSIS AND FAIR DECISION MAKING].[健康经济分析与公平决策]
Rev Prat. 2015 Sep;65(7):909-11.

引用本文的文献

1
Deriving disability weights for the Netherlands: findings from the Dutch disability weights measurement study.为荷兰制定残疾权重:荷兰残疾权重测量研究的结果。
Popul Health Metr. 2024 Oct 7;22(1):26. doi: 10.1186/s12963-024-00342-0.
2
Disability Weights Measurement for 228 Causes of Disease in the Korean Burden of Disease Study 2012.《2012年韩国疾病负担研究中228种疾病的残疾权重测量》
J Korean Med Sci. 2016 Nov;31 Suppl 2(Suppl 2):S129-S138. doi: 10.3346/jkms.2016.31.S2.S129.
3
Cost-Value Analysis and the SAVE: A Work in Progress, But an Option for Localised Decision Making?成本-价值分析与SAVE:一项正在进行的工作,但能否成为本地化决策的一个选项?
Pharmacoeconomics. 2015 Dec;33(12):1281-8. doi: 10.1007/s40273-015-0308-5.

本文引用的文献

1
Person tradeoffs and the problem of risk.个人权衡与风险问题。
Expert Rev Pharmacoecon Outcomes Res. 2005 Dec;5(6):677-82. doi: 10.1586/14737167.5.6.677.
2
Aversion to health inequalities and priority setting in health care.对健康不平等现象的厌恶以及医疗保健中的优先事项设定
J Health Econ. 2008 Dec;27(6):1594-604. doi: 10.1016/j.jhealeco.2008.07.004. Epub 2008 Jul 23.
3
Trading people versus trading time: what is the difference?交易人还是交易时间:有何不同?
Popul Health Metr. 2005 Nov 10;3:10. doi: 10.1186/1478-7954-3-10.
4
The validity of person tradeoff measurements: randomized trial of computer elicitation versus face-to-face interview.个人权衡测量的有效性:计算机诱导与面对面访谈的随机试验
Med Decis Making. 2004 Mar-Apr;24(2):170-80. doi: 10.1177/0272989X04263160.
5
A multi-method approach to measuring health-state valuations.一种用于衡量健康状态估值的多方法途径。
Health Econ. 2004 Mar;13(3):281-90. doi: 10.1002/hec.834.
6
The person trade-off method and the transitivity principle: an example from preferences over age weighting.个人权衡法与可传递性原则:年龄加权偏好的一个例子
Health Econ. 2003 Jun;12(6):505-10. doi: 10.1002/hec.731.
7
Improving value measurement in cost-effectiveness analysis.提高成本效益分析中的价值衡量
Med Care. 2000 Sep;38(9):892-901. doi: 10.1097/00005650-200009000-00003.
8
On the shape of the probability weighting function.论概率加权函数的形状。
Cogn Psychol. 1999 Feb;38(1):129-66. doi: 10.1006/cogp.1998.0710.
9
Incorporating societal concerns for fairness in numerical valuations of health programmes.将社会对公平性的关注纳入卫生项目的数值评估中。
Health Econ. 1999 Feb;8(1):25-39. doi: 10.1002/(sici)1099-1050(199902)8:1<25::aid-hec398>3.0.co;2-h.
10
Using the person trade-off approach to examine differences between individual and social values.运用个人权衡方法来检验个人价值观与社会价值观之间的差异。
Health Econ. 1998 Jun;7(4):307-12. doi: 10.1002/(sici)1099-1050(199806)7:4<307::aid-hec345>3.0.co;2-n.